| Name | Kif15-IN-1 | 
|---|---|
| Synonyms | 5-Thiazolecarboxylic acid, 2-[[(2S)-2-(1,4-dihydro-2,4-dioxo-3(2H)-quinazolinyl)-3-methyl-1-oxobutyl]amino]-4-methyl-, ethyl ester Ethyl 2-{[(2S)-2-(2,4-dioxo-1,4-dihydro-3(2H)-quinazolinyl)-3-methylbutanoyl]amino}-4-methyl-1,3-thiazole-5-carboxylate | 
| Description | Kif15-IN-1 is an inhibitor of the mitotic kinesin Kif15, and is used for the research of cellular proliferative diseases. | 
|---|---|
| Related Catalog | |
| Target | KIF15 | 
| In Vitro | Kif15-IN-1 (Compound 10) is an inhibitor of the mitotic kinesin Hs Kif15, with the potential activities against cellular proliferative diseases such as cancer, hyperplasias, restenosis, cardiac hypertrophy, immune disorders and inflammation[1]. | 
| References | 
| Density | 1.4±0.1 g/cm3 | 
|---|---|
| Molecular Formula | C20H22N4O5S | 
| Molecular Weight | 430.478 | 
| Exact Mass | 430.131104 | 
| LogP | 3.73 | 
| Index of Refraction | 1.619 | 
| Storage condition | 2-8℃ |